Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Competent Cells Market, by Type
1.4.2 North America Competent Cells Market, by Application
1.4.3 North America Competent Cells Market, by End-Use
1.4.4 North America Competent Cells Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Competent Cells Market
Chapter 5. North America Competent Cells Market by Type
5.1 North America Chemically Competent Cells Market by Country
5.2 North America Electrocompetent Cells Market by Country
5.3 North America Ultracompetent Cells Market by Country
Chapter 6. North America Competent Cells Market by Application
6.1 North America Cloning Market by Country
6.2 North America Protein Expression Market by Country
6.3 North America Mutagenesis Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Competent Cells Market by End-Use
7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
7.2 North America Academic & Research Institutes Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Competent Cells Market by Country
8.1 US Competent Cells Market
8.1.1 US Competent Cells Market by Type
8.1.2 US Competent Cells Market by Application
8.1.3 US Competent Cells Market by End-Use
8.2 Canada Competent Cells Market
8.2.1 Canada Competent Cells Market by Type
8.2.2 Canada Competent Cells Market by Application
8.2.3 Canada Competent Cells Market by End-Use
8.3 Mexico Competent Cells Market
8.3.1 Mexico Competent Cells Market by Type
8.3.2 Mexico Competent Cells Market by Application
8.3.3 Mexico Competent Cells Market by End-Use
8.4 Rest of North America Competent Cells Market
8.4.1 Rest of North America Competent Cells Market by Type
8.4.2 Rest of North America Competent Cells Market by Application
8.4.3 Rest of North America Competent Cells Market by End-Use
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Merck KGaA
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Trail and Approvals:
9.3.6 SWOT Analysis
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Promega Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Partnerships, Collaborations, and Agreements:
9.5.3 SWOT Analysis
9.6 New England Biolabs, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Takara Bio Inc. (Takara Holdings Inc.)
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. Lonza Group Ltd. (Capsugel)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Unique Offerings 